MHRA Drug Safety Update March 2019

MHRA Drug Safety Update March 2019

March 21, 2019

Date issued: 21st March 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 8 March 2019:1) has been published and includes articles on:

  • Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
  • Onivyde (irinotecan, liposomal formulations): reports of serious and fatal thromboembolic events
  • Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
  • Letters and drug alerts sent to healthcare professionals on February 2019
  • Medical Device Alerts Issued in February 2019

To see the latest MHRA Drug Safety Update in full, visit the website.


Posted in:

More Latest News >

DHSC EU Exit Communication

Community pharmacy teams will be aware that Government has agreed a further extension of the EU exit date to 31st...

Shortage of Labetalol tablets

Specialist Pharmacy Service (SPS) advises that there is currently a shortage of Labetalol 50mg, 100mg, 200mg and 400mg tablets. The...